financetom
Business
financetom
/
Business
/
Super Micro Computer (SMCI) Shares Pull Back After Earnings Rally: What Investors Need To Know
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Super Micro Computer (SMCI) Shares Pull Back After Earnings Rally: What Investors Need To Know
Mar 11, 2026 3:25 AM

Shares of Super Micro Computer Inc ( SMCI ) are trading slightly lower Monday morning, giving back a portion of last week's post-earnings rally as investors digested analyst rating updates and ongoing volatility in the high-flying AI server name. Here’s what investors need to know.

Super Micro Computer ( SMCI ) stock is taking a hit today. What’s pressuring SMCI stock?

Earnings Beat Highlights Strong AI-Driven Demand

The move comes after Super Micro reported fiscal second-quarter results last week that topped Wall Street expectations. The company posted adjusted earnings of 69 cents per share on revenue of $12.68 billion, ahead of consensus estimates of 49 cents and $10.21 billion, respectively.

Management also guided third-quarter revenue to about $12.3 billion and forecast full-year sales of roughly $40 billion, both above analyst projections.

Analysts Maintain Bullish Ratings, Cut Targets

Despite the beat-and-raise quarter, several Wall Street firms trimmed their price targets while reiterating bullish views, a combination that appears to be fueling choppy trading.

Needham maintained a Buy rating but cut its target to $40 from $51, while Rosenblatt also kept a Buy and lowered its target to $50 from $55. Barclays likewise stayed positive on the name but reduced its target to $38 from $43.

Even after the target reductions, all three firms continue to see meaningful upside from current levels, with implied gains ranging from the mid-teens to more than 50%.

Mixed Technical Picture For SMCI

The stock is currently trading 7.4% above its 20-day simple moving average (SMA) but is 14.7% below its 100-day SMA, demonstrating a mixed technical picture.

Over the past 12 months, shares have decreased by 21.89%, and they are currently positioned closer to their 52-week lows than highs, indicating ongoing challenges.

The RSI is at 60.09, which is considered neutral territory, while the MACD is above its signal line, suggesting bullish momentum. However,

the combination of neutral RSI and bullish MACD indicates mixed momentum, reflecting uncertainty in the stock’s short-term trajectory.

Key Resistance: $33.50

Key Support: $29.00

SMCI Shares Fall Monday Morning

SMCI Price Action: Super Micro Computer ( SMCI ) shares were down 1.57% at $33.84 at the time of publication on Monday, according to Benzinga Pro data.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
InflaRx Says Phase 2a Data Support Further Development of INF904 in 2 Skin Conditions
InflaRx Says Phase 2a Data Support Further Development of INF904 in 2 Skin Conditions
Nov 10, 2025
10:44 AM EST, 11/10/2025 (MT Newswires) -- InflaRx ( IFRX ) said Monday that a phase 2a study evaluating INF904 in hidradenitis suppurative, or HS, and chronic spontaneous urticaria, or CSU, demonstrated improvements in clinical endpoints, supporting its further development in both indications. Clinical endpoints for HS include reduction in abscesses and nodules, and draining tunnels, which the product candidate...
AnaptysBio's Rosnilimab Misses Endpoints in Phase 2 Ulcerative Colitis Study; Shares Fall
AnaptysBio's Rosnilimab Misses Endpoints in Phase 2 Ulcerative Colitis Study; Shares Fall
Nov 10, 2025
10:42 AM EST, 11/10/2025 (MT Newswires) -- AnaptysBio ( ANAB ) said Monday its phase 2 trial of rosnilimab in ulcerative colitis failed to meet its primary endpoint and key secondary goals. The placebo-controlled study evaluated rosnilimab in patients with moderate-to-severe ulcerative colitis, a chronic inflammatory disease of the colon. Data show that rosnilimab was safe and well tolerated; however,...
P2 Gold Provides Gabbs Project Update; Shares up 13%
P2 Gold Provides Gabbs Project Update; Shares up 13%
Nov 10, 2025
10:43 AM EST, 11/10/2025 (MT Newswires) -- P2 Gold ( PGLDF ) earlier Monday provided an update on activities at its wholly-owned gold-copper Gabbs Project located on the Walker-Lane Trend in Nevada. The company said that a reverse circulation (RC) drill rig was mobilized to site on Oct 22, 2025, and expansion and infill drilling is underway. It added that,...
Loop Industries Enters Offtake Agreement With Nike to Supply Polyester Resin
Loop Industries Enters Offtake Agreement With Nike to Supply Polyester Resin
Nov 10, 2025
10:41 AM EST, 11/10/2025 (MT Newswires) -- Loop Industries ( LOOP ) said Monday that it has reached a multi-year offtake agreement with Nike ( NKE ) to supply its Twist polyester resin from its manufacturing facility in India. Loop said the offtake deal makes Nike ( NKE ) the anchor customer for its Infinite Loop India manufacturing facility, which...
Copyright 2023-2026 - www.financetom.com All Rights Reserved